IMAGINE study protocol of a clinical trial: a multi-center, investigator-blinded, randomized, 36-month, parallel-group to compare the effectiveness of motivational interview in rehabilitation of older stroke survivors.

Adherence Clinical trial Functional recovery Geriatrics Motivational interviewing Physical activity Rehabilitation Stroke

Journal

BMC geriatrics
ISSN: 1471-2318
Titre abrégé: BMC Geriatr
Pays: England
ID NLM: 100968548

Informations de publication

Date de publication:
04 09 2020
Historique:
received: 09 04 2020
accepted: 10 08 2020
entrez: 5 9 2020
pubmed: 6 9 2020
medline: 22 12 2020
Statut: epublish

Résumé

Rehabilitation pathways are crucial to reduce stroke-related disability. Motivational Interviewing (MI), as a person-centered complex intervention, aimed to empower and motivate, and could be a resource to improve rehabilitation outcomes for older stroke survivors. The IMAGINE project aims to assess the impact of MI, as a complement to standard geriatric rehabilitation, on functional improvement at 30 days after admission, compared to standard geriatric rehabilitation alone, in persons admitted to geriatric rehabilitation after a stroke. Secondary objectives include assessing the impact of MI on physical activity and performance, self-efficacy, safety, cost-utility, participants' experiences and functional status at 3 months. We will conduct a multicenter randomized clinical trial in three geriatric rehabilitation hospitals in Spain. Older adults after mild-moderate stroke without previous severe cognitive impairment or disability will be randomized into the control or intervention group (136 per group, total N = 272). The intervention group will receive 4 sessions of MI by trained nurses, including the design of a personalized rehabilitation plan agreed between stroke survivors and nurses based on stroke survivors´ goals, needs, preferences and capabilities. Main outcome will be the Functional Independence Measure (FIM). In-hospital physical activity will be measured through accelerometers and secondary outcomes using validated scales. The study includes a process evaluation and cost-utility analysis. Final results are expected by end of 2020. This study will provide relevant information on the implementation of MI as a rehabilitation reinforcement tool in older stroke survivors. A potential reduction in post-stroke disability and dependence would increase person's health-related quality of life and well-being and reduce health and social care costs. IMAGINE has the potential to inform practice and policymakers on how to move forward towards shared decision-making and shared responsibilities in the vulnerable population of older stroke survivors. ClinicalTrials.gov: NCT03434938 , registered on January 2018.

Sections du résumé

BACKGROUND
Rehabilitation pathways are crucial to reduce stroke-related disability. Motivational Interviewing (MI), as a person-centered complex intervention, aimed to empower and motivate, and could be a resource to improve rehabilitation outcomes for older stroke survivors. The IMAGINE project aims to assess the impact of MI, as a complement to standard geriatric rehabilitation, on functional improvement at 30 days after admission, compared to standard geriatric rehabilitation alone, in persons admitted to geriatric rehabilitation after a stroke. Secondary objectives include assessing the impact of MI on physical activity and performance, self-efficacy, safety, cost-utility, participants' experiences and functional status at 3 months.
METHODS
We will conduct a multicenter randomized clinical trial in three geriatric rehabilitation hospitals in Spain. Older adults after mild-moderate stroke without previous severe cognitive impairment or disability will be randomized into the control or intervention group (136 per group, total N = 272). The intervention group will receive 4 sessions of MI by trained nurses, including the design of a personalized rehabilitation plan agreed between stroke survivors and nurses based on stroke survivors´ goals, needs, preferences and capabilities. Main outcome will be the Functional Independence Measure (FIM). In-hospital physical activity will be measured through accelerometers and secondary outcomes using validated scales. The study includes a process evaluation and cost-utility analysis.
DISCUSSION
Final results are expected by end of 2020. This study will provide relevant information on the implementation of MI as a rehabilitation reinforcement tool in older stroke survivors. A potential reduction in post-stroke disability and dependence would increase person's health-related quality of life and well-being and reduce health and social care costs. IMAGINE has the potential to inform practice and policymakers on how to move forward towards shared decision-making and shared responsibilities in the vulnerable population of older stroke survivors.
TRIAL REGISTRATION
ClinicalTrials.gov: NCT03434938 , registered on January 2018.

Identifiants

pubmed: 32887564
doi: 10.1186/s12877-020-01694-6
pii: 10.1186/s12877-020-01694-6
pmc: PMC7472581
doi:

Banques de données

ClinicalTrials.gov
['NCT03434938']

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

321

Subventions

Organisme : Fundació la Marató de TV3
ID : ID 373/U/2017
Pays : International

Références

J Am Geriatr Soc. 2000 Sep;48(9):1132-5
pubmed: 10983915
Arch Phys Med Rehabil. 2016 Feb;97(2):273-80
pubmed: 26529471
Stroke. 1988 Dec;19(12):1497-500
pubmed: 3201508
J Am Geriatr Soc. 2011 May;59(5):893-9
pubmed: 21568958
BMJ. 2013 Jan 08;346:e7586
pubmed: 23303884
PLoS One. 2014 Oct 29;9(10):e110761
pubmed: 25353169
Health Serv Res. 1972 Summer;7(2):118-33
pubmed: 5044699
Arch Phys Med Rehabil. 2017 Apr;98(4):759-765
pubmed: 27993584
Stroke. 2007 Mar;38(3):1004-9
pubmed: 17303766
Med Sci Sports Exerc. 2012 Jan;44(1 Suppl 1):S68-76
pubmed: 22157777
Stroke. 2011 Jul;42(7):1956-61
pubmed: 21700946
Cochrane Database Syst Rev. 2011 May 11;(5):CD008063
pubmed: 21563163
Stroke. 2016 Jun;47(6):e98-e169
pubmed: 27145936
Disabil Rehabil. 2005 Mar 18;27(6):315-40
pubmed: 16040533
Qual Life Res. 2013 Jun;22(5):1099-104
pubmed: 22836376
Stroke. 2015 Dec;46(12):3451-8
pubmed: 26508749
Soc Sci Med. 2018 Aug;211:359-366
pubmed: 30015244
Lancet. 2011 May 14;377(9778):1693-702
pubmed: 21571152
Cochrane Database Syst Rev. 2007 Oct 17;(4):CD000197
pubmed: 17943737
Arch Phys Med Rehabil. 2006 Jan;87(1):32-9
pubmed: 16401435
Aten Primaria. 1996 Sep 15;18(4):153-6, 158-63
pubmed: 8962994
Nurs Times. 2012 Nov 20-26;108(47):12-5
pubmed: 23495577
PLoS One. 2016 Jun 10;11(6):e0157149
pubmed: 27285997
Circulation. 2016 Jan 26;133(4):e38-360
pubmed: 26673558
PLoS One. 2017 Mar 27;12(3):e0173291
pubmed: 28346532
Neuropsychol Rehabil. 2009 Aug;19(4):481-516
pubmed: 19533496
Clin Rehabil. 1999 Aug;13(4):277-87
pubmed: 10460115
PM R. 2015 Jun;7(6):562-70
pubmed: 25595665
BMJ. 2015 Mar 19;350:h1258
pubmed: 25791983
Clin Rehabil. 2015 Apr;29(4):365-75
pubmed: 25142277
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Disabil Rehabil. 2013 Feb;35(3):177-90
pubmed: 22671934
Disabil Rehabil. 2018 Feb;40(3):309-316
pubmed: 27866416
BMJ. 2014 Mar 07;348:g1687
pubmed: 24609605
Int J Stroke. 2014 Jan;9(1):133-9
pubmed: 24165269
Cochrane Database Syst Rev. 2015 Jun 03;(6):CD011398
pubmed: 26037617
Disabil Health J. 2011 Jul;4(3):141-2
pubmed: 21723520
Circulation. 2015 Jan 27;131(4):e29-322
pubmed: 25520374
BMC Med Inform Decis Mak. 2013;13 Suppl 2:S2
pubmed: 24625093
Value Health. 2008 Mar-Apr;11(2):191-8
pubmed: 17854434
Top Stroke Rehabil. 2011 Sep-Oct;18(5):461-9
pubmed: 22082697
J Gerontol A Biol Sci Med Sci. 2013 Sep;68(9):1059-67
pubmed: 23666944
Med Clin (Barc). 2005 Dec 1;125 Suppl 1:8-13
pubmed: 16464421
Stroke. 2013 Oct;44(10):2854-61
pubmed: 23920019
Nutr Hosp. 2011 Nov-Dec;26(6):1350-4
pubmed: 22411382
Ann Intern Med. 2013 Feb 5;158(3):200-7
pubmed: 23295957
Disabil Rehabil. 2013;35(22):1921-5
pubmed: 23530624
PM R. 2017 Sep;9(9):856-865
pubmed: 28082180
Acta Derm Venereol. 2016 Jun 15;96(5):664-8
pubmed: 26714522
Lancet. 2014 Jan 18;383(9913):245-54
pubmed: 24449944
J Subst Abuse Treat. 2016 Jun;65:36-42
pubmed: 26874558
Clin Rehabil. 2019 Mar;33(3):395-407
pubmed: 30537854
Health Policy. 1990 Dec;16(3):199-208
pubmed: 10109801
J Cachexia Sarcopenia Muscle. 2016 Sep;7(4):422-35
pubmed: 27239405

Auteurs

Neus Gual (N)

REFiT BCN Research Group-Parc Sanitari Pere Virgili-Vall d'Hebron Institute of Research, Barcelona, Spain.

Laura Mónica Pérez (LM)

REFiT BCN Research Group-Parc Sanitari Pere Virgili-Vall d'Hebron Institute of Research, Barcelona, Spain.

Carmina Castellano-Tejedor (C)

REFiT BCN Research Group-Parc Sanitari Pere Virgili-Vall d'Hebron Institute of Research, Barcelona, Spain. ccastellano@perevirgili.cat.
Autonomous University of Barcelona, Bellaterra, Spain. ccastellano@perevirgili.cat.

Pilar Lusilla-Palacios (P)

Psychiatry Department, University Hospital Vall d'Hebron, Barcelona, Spain.

Judith Castro (J)

REFiT BCN Research Group-Parc Sanitari Pere Virgili-Vall d'Hebron Institute of Research, Barcelona, Spain.

Luís Soto-Bagaria (L)

REFiT BCN Research Group-Parc Sanitari Pere Virgili-Vall d'Hebron Institute of Research, Barcelona, Spain.

Laura Coll-Planas (L)

Fundació Salut i Envelliment (Foundation on Health and Ageing), Universitat Autònoma de Barcelona, Barcelona, Spain.
Institute of Biomedical Research (IIB Sant Pau), Barcelona, Spain.

Marta Roqué (M)

Fundació Salut i Envelliment (Foundation on Health and Ageing), Universitat Autònoma de Barcelona, Barcelona, Spain.
Institute of Biomedical Research (IIB Sant Pau), Barcelona, Spain.

Ana Belen Vena (AB)

University Hospital Santa Maria, Lleida, Spain.

Benito Fontecha (B)

Hospital General de l'Hospitalet (Consorci Sanitari Integral), Hospitalet de Llobregat, Spain.

Jose M Santiago (JM)

Hospital General de l'Hospitalet (Consorci Sanitari Integral), Hospitalet de Llobregat, Spain.

Eva Månsson Lexell (EM)

Department of Health Sciences, Lund University, Lund, Sweden.
Department of Neurology and Rehabilitation Medicine, Skåne University Hospital, Lund-Malmö, Sweden.

Carlos Chiatti (C)

Department of Health Sciences, Lund University, Lund, Sweden.
Department of Neurology and Rehabilitation Medicine, Skåne University Hospital, Lund-Malmö, Sweden.

Susanne Iwarsson (S)

Department of Health Sciences, Lund University, Lund, Sweden.
Department of Neurology and Rehabilitation Medicine, Skåne University Hospital, Lund-Malmö, Sweden.

Marco Inzitari (M)

REFiT BCN Research Group-Parc Sanitari Pere Virgili-Vall d'Hebron Institute of Research, Barcelona, Spain.
Autonomous University of Barcelona, Bellaterra, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH